Report Detail

Medical Devices & Consumables Global Non-invasive Neuromodulation Device Market Research Report 2021

  • RnM4300550
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 121 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Non-invasive Neuromodulation Device Market Overview

  • 1.1 Product Overview and Scope of Non-invasive Neuromodulation Device
  • 1.2 Non-invasive Neuromodulation Device Segment by Type
    • 1.2.1 Global Non-invasive Neuromodulation Device Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Transcranial Direct Current Stimulation (tDCS)
    • 1.2.3 Transcranial Alternating Current Stimulation (tACS)
    • 1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
    • 1.2.5 Transcranial Random Noise Stimulation (tRNS)
    • 1.2.6 Electroconvulsive therapy (ECT)
    • 1.2.7 Others
  • 1.3 Non-invasive Neuromodulation Device Segment by Application
    • 1.3.1 Non-invasive Neuromodulation Device Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Others
  • 1.4 Global Non-invasive Neuromodulation Device Market Size Estimates and Forecasts
    • 1.4.1 Global Non-invasive Neuromodulation Device Revenue 2016-2027
    • 1.4.2 Global Non-invasive Neuromodulation Device Sales 2016-2027
    • 1.4.3 Non-invasive Neuromodulation Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-invasive Neuromodulation Device Market Competition by Manufacturers

  • 2.1 Global Non-invasive Neuromodulation Device Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Non-invasive Neuromodulation Device Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Non-invasive Neuromodulation Device Manufacturing Sites, Area Served, Product Type
  • 2.5 Non-invasive Neuromodulation Device Market Competitive Situation and Trends
    • 2.5.1 Non-invasive Neuromodulation Device Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Non-invasive Neuromodulation Device Players Market Share by Revenue
    • 2.5.3 Global Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-invasive Neuromodulation Device Retrospective Market Scenario by Region

  • 3.1 Global Non-invasive Neuromodulation Device Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Non-invasive Neuromodulation Device Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Non-invasive Neuromodulation Device Market Facts & Figures by Country
    • 3.3.1 North America Non-invasive Neuromodulation Device Sales by Country
    • 3.3.2 North America Non-invasive Neuromodulation Device Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Non-invasive Neuromodulation Device Market Facts & Figures by Country
    • 3.4.1 Europe Non-invasive Neuromodulation Device Sales by Country
    • 3.4.2 Europe Non-invasive Neuromodulation Device Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Non-invasive Neuromodulation Device Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Region
    • 3.5.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Non-invasive Neuromodulation Device Market Facts & Figures by Country
    • 3.6.1 Latin America Non-invasive Neuromodulation Device Sales by Country
    • 3.6.2 Latin America Non-invasive Neuromodulation Device Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Non-invasive Neuromodulation Device Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Country
    • 3.7.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Non-invasive Neuromodulation Device Historic Market Analysis by Type

  • 4.1 Global Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)
  • 4.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2016-2021)
  • 4.3 Global Non-invasive Neuromodulation Device Price by Type (2016-2021)

5 Global Non-invasive Neuromodulation Device Historic Market Analysis by Application

  • 5.1 Global Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)
  • 5.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2016-2021)
  • 5.3 Global Non-invasive Neuromodulation Device Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Neuroelectrics
    • 6.1.1 Neuroelectrics Corporation Information
    • 6.1.2 Neuroelectrics Description and Business Overview
    • 6.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Neuroelectrics Product Portfolio
    • 6.1.5 Neuroelectrics Recent Developments/Updates
  • 6.2 Magstim
    • 6.2.1 Magstim Corporation Information
    • 6.2.2 Magstim Description and Business Overview
    • 6.2.3 Magstim Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Magstim Product Portfolio
    • 6.2.5 Magstim Recent Developments/Updates
  • 6.3 NeuroCare Group
    • 6.3.1 NeuroCare Group Corporation Information
    • 6.3.2 NeuroCare Group Description and Business Overview
    • 6.3.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 NeuroCare Group Product Portfolio
    • 6.3.5 NeuroCare Group Recent Developments/Updates
  • 6.4 Soterix Medical
    • 6.4.1 Soterix Medical Corporation Information
    • 6.4.2 Soterix Medical Description and Business Overview
    • 6.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Soterix Medical Product Portfolio
    • 6.4.5 Soterix Medical Recent Developments/Updates
  • 6.5 Newronika
    • 6.5.1 Newronika Corporation Information
    • 6.5.2 Newronika Description and Business Overview
    • 6.5.3 Newronika Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Newronika Product Portfolio
    • 6.5.5 Newronika Recent Developments/Updates
  • 6.6 Rogue Resolutions
    • 6.6.1 Rogue Resolutions Corporation Information
    • 6.6.2 Rogue Resolutions Description and Business Overview
    • 6.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Rogue Resolutions Product Portfolio
    • 6.6.5 Rogue Resolutions Recent Developments/Updates
  • 6.7 Medtronic
    • 6.6.1 Medtronic Corporation Information
    • 6.6.2 Medtronic Description and Business Overview
    • 6.6.3 Medtronic Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Medtronic Product Portfolio
    • 6.7.5 Medtronic Recent Developments/Updates
  • 6.8 Philips Healthcare
    • 6.8.1 Philips Healthcare Corporation Information
    • 6.8.2 Philips Healthcare Description and Business Overview
    • 6.8.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Philips Healthcare Product Portfolio
    • 6.8.5 Philips Healthcare Recent Developments/Updates
  • 6.9 Shenzhen Yingchi Technology
    • 6.9.1 Shenzhen Yingchi Technology Corporation Information
    • 6.9.2 Shenzhen Yingchi Technology Description and Business Overview
    • 6.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Shenzhen Yingchi Technology Product Portfolio
    • 6.9.5 Shenzhen Yingchi Technology Recent Developments/Updates
  • 6.10 Shenzhen Hanix United
    • 6.10.1 Shenzhen Hanix United Corporation Information
    • 6.10.2 Shenzhen Hanix United Description and Business Overview
    • 6.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Shenzhen Hanix United Product Portfolio
    • 6.10.5 Shenzhen Hanix United Recent Developments/Updates
  • 6.11 Shanghai Qiankang Medical Care Company
    • 6.11.1 Shanghai Qiankang Medical Care Company Corporation Information
    • 6.11.2 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Description and Business Overview
    • 6.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Shanghai Qiankang Medical Care Company Product Portfolio
    • 6.11.5 Shanghai Qiankang Medical Care Company Recent Developments/Updates
  • 6.12 TCT Research
    • 6.12.1 TCT Research Corporation Information
    • 6.12.2 TCT Research Non-invasive Neuromodulation Device Description and Business Overview
    • 6.12.3 TCT Research Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 TCT Research Product Portfolio
    • 6.12.5 TCT Research Recent Developments/Updates
  • 6.13 EB Neuro SpA
    • 6.13.1 EB Neuro SpA Corporation Information
    • 6.13.2 EB Neuro SpA Non-invasive Neuromodulation Device Description and Business Overview
    • 6.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 EB Neuro SpA Product Portfolio
    • 6.13.5 EB Neuro SpA Recent Developments/Updates

7 Non-invasive Neuromodulation Device Manufacturing Cost Analysis

  • 7.1 Non-invasive Neuromodulation Device Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Non-invasive Neuromodulation Device
  • 7.4 Non-invasive Neuromodulation Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Non-invasive Neuromodulation Device Distributors List
  • 8.3 Non-invasive Neuromodulation Device Customers

9 Non-invasive Neuromodulation Device Market Dynamics

  • 9.1 Non-invasive Neuromodulation Device Industry Trends
  • 9.2 Non-invasive Neuromodulation Device Growth Drivers
  • 9.3 Non-invasive Neuromodulation Device Market Challenges
  • 9.4 Non-invasive Neuromodulation Device Market Restraints

10 Global Market Forecast

  • 10.1 Non-invasive Neuromodulation Device Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Non-invasive Neuromodulation Device by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Non-invasive Neuromodulation Device by Type (2022-2027)
  • 10.2 Non-invasive Neuromodulation Device Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Non-invasive Neuromodulation Device by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Non-invasive Neuromodulation Device by Application (2022-2027)
  • 10.3 Non-invasive Neuromodulation Device Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Non-invasive Neuromodulation Device by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Non-invasive Neuromodulation Device by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Transcranial Direct Current Stimulation (tDCS)
    Transcranial Alternating Current Stimulation (tACS)
    Transcranial Pulsed Current Stimulation (tPCS)
    Transcranial Random Noise Stimulation (tRNS)
    Electroconvulsive therapy (ECT)
    Others

    Segment by Application
    Hospital
    Clinic
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Neuroelectrics
    Magstim
    NeuroCare Group
    Soterix Medical
    Newronika
    Rogue Resolutions
    Medtronic
    Philips Healthcare
    Shenzhen Yingchi Technology
    Shenzhen Hanix United
    Shanghai Qiankang Medical Care Company
    TCT Research
    EB Neuro SpA


    Summary:
    Get latest Market Research Reports on Non-invasive Neuromodulation Device. Industry analysis & Market Report on Non-invasive Neuromodulation Device is a syndicated market report, published as Global Non-invasive Neuromodulation Device Market Research Report 2021. It is complete Research Study and Industry Analysis of Non-invasive Neuromodulation Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,108.83
    3,163.25
    4,217.67
    2,432.67
    3,649.00
    4,865.33
    317,445.60
    476,168.40
    634,891.20
    217,376.75
    326,065.13
    434,753.50
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report